Previous Article | Next Article 
Applied and Environmental Microbiology, April 2001, p. 1558-1564, Vol. 67, No. 4
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.4.1558-1564.2001
Identification and Characterization of Integron-Mediated
Antibiotic Resistance among Shiga Toxin-Producing Escherichia
coli Isolates
Shaohua
Zhao,1,*
David G.
White,1
Beilei
Ge,2
Sherry
Ayers,1
Sharon
Friedman,1
Linda
English,1
David
Wagner,1
Stuart
Gaines,1 and
Jianghong
Meng2
Division of Animal and Food Microbiology,
Office of Research, Center for Veterinary Medicine, U.S. Food and
Drug Administration, Laurel, Maryland 20708,1
and Department of Nutrition and Food Science, University of
Maryland, College Park, Maryland 207422
Received 5 May 2000/Accepted 7 January 2001
 |
ABSTRACT |
A total of 50 isolates of Shiga toxin-producing Escherichia
coli (STEC), including 29 O157:H7 and 21 non-O157 STEC strains, were analyzed for antimicrobial susceptibilities and the presence of
class 1 integrons. Seventy-eight (n = 39) percent of
the isolates exhibited resistance to two or more antimicrobial
classes. Multiple resistance to streptomycin, sulfamethoxazole,
and tetracycline was most often observed. Class 1 integrons
were identified among nine STEC isolates, including serotypes
O157:H7, O111:H11, O111:H8, O111:NM, O103:H2, O45:H2, O26:H11,
and O5:NM. The majority of the amplified integron fragments were 1 kb
in size with the exception of one E. coli O111:H8 isolate
which possessed a 2-kb amplicon. DNA sequence analysis revealed that
the integrons identified within the O111:H11, O111:NM, O45:H2, and
O26:H11 isolates contained the aadA gene encoding
resistance to streptomycin and spectinomycin. Integrons identified
among the O157:H7 and O103:H2 isolates also possessed a similar
aadA gene. However, DNA sequencing revealed only 86 and
88% homology, respectively. The 2-kb integron of the E. coli O111:H8 isolate contained three genes, dfrXII,
aadA2, and a gene of unknown function, orfF,
which were 86, 100, and 100% homologous, respectively, to
previously reported gene cassettes identified in integrons found in
Citrobacter freundii and Klebsiella pneumoniae.
Furthermore, integrons identified among the O157:H7 and O111:NM strains
were transferable via conjugation to another strain of E. coli O157:H7 and to several strains of Hafnia alvei. To our knowledge, this is the first report of integrons and antibiotic resistance gene cassettes in STEC, in particular E. coli
O157:H7.
 |
INTRODUCTION |
Shiga toxin-producing
Escherichia coli (STEC) have been an important cause of
foodborne illness worldwide. Human infection with STEC is potentially
fatal and may be associated with serious complications such as
hemolytic -uremic syndrome (HUS) and hemorrhagic colitis
(7). Among STEC strains, O157:H7 is the classical serotype that was first associated with enterohemorrhagic diseases in the early
1980s as a cause of serious foodborne disease outbreaks. Since then,
over 100 STEC serotypes, other than O157:H7, have been associated with
human illness (17). In the United States approximately
73,000 cases of infections annually have been attributed to O157:H7
strains and more than 36,000 to non-O157:H7 STEC strains (16). There are more than 100 deaths each year due to STEC
infections. Several studies in Japan have suggested that initiation of
antibiotic therapy early in the stages of STEC infection was able to
prevent the disease progression to HUS (5, 11, 30).
However, antimicrobial treatment for STEC infections is still regarded
as controversial (10, 23, 35). Currently, no specific
therapy for HUS is available, and most patients require prolonged
clinical and outpatient treatment (31).
Initially, E. coli O157:H7 was found to be susceptible to
many antibiotics (3, 24). However, several recent studies
have documented antibiotic resistance among E. coli O157:H7
isolates (4, 13, 19, 29). Non-O157 STEC strains isolated
from humans and animals also have developed antibiotic resistance, and
many are resistant to multiple antimicrobials commonly used in human
and veterinary medicine (4, 6, 29). There is currently a
great deal of speculation regarding the role that the therapeutic and
subtherapeutic use of antimicrobials in animals has played in
accelerating the development and dissemination of antimicrobial-resistant bacterial pathogens (1, 33, 34). Research is urgently needed to determine the potential effect of
antimicrobials used in animal production environments on the emergence
and spread of bacterial antibiotic resistance in both veterinary and
human medicine.
A novel system has been identified in multiple resistant bacteria and
is postulated to play an important role in the acquisition and
dissemination of antibiotic resistance genes (8). This system has been referred to as bacterial integrons. Integrons are
mobile DNA elements with a specific structure consisting of two
conserved segments flanking a central region containing "cassettes" that usually code for resistance to specific antimicrobials
(9). Four classes of integrons have been identified to
date (15). The majority of integrons identified among
clinical isolates belong to class 1 type (12, 27). In
class 1 integrons, the 5' conserved region encodes a site-specific
recombinase (integrase) and a strong promoter or promoters that ensure
expression of the integrated cassettes. The 3' conserved segment
carries qac
E, which specifies resistance to antiseptics
and disinfectants; the sul-1 gene, which confers sulfonamide
resistance; and an open reading frame of unknown function
(9). Multiple cassette insertions and more than 40 distinct cassettes have been identified among integrons
(25). Currently, there is a paucity of data regarding the
mechanisms of acquisition and dissemination of antibiotic resistance in
E. coli O157:H7 and other STEC. This study was
initiated to characterize antimicrobial susceptibility patterns among
STEC strains, including E. coli O157:H7, isolated from
cattle, ground beef, and humans and to determine if resistance
phenotypes observed could be attributed to the acquisition of
integron-mediated resistance gene cassettes.
 |
MATERIALS AND METHODS |
Bacterial strains.
A total of 50 STEC isolates including 29 O157:H7 strains and 21 non-O157 STEC strains from humans, animals, and
foods were used in the study (Table 1).
The STEC isolates originated from humans (n = 8),
cattle (n = 32), and ground beef (n = 10). The 29 E. coli O157:H7 strains were selected among
118 isolates from a previous study (19) and were resistant
to at least one antibiotic based on disk diffusion in vitro
susceptibility testing (Difco, Detroit, Mich). Salmonella
enterica serovar Typhimurium DT104 CVM786 was used as a positive
control for integron PCR reactions. Three Hafnia alvei
strains isolated from ground beef and one strain of E. coli
O157:H7 originating from human stools were used as recipient strains in
conjugation experiments. Bacteria were grown on MacConkey agar (Difco)
and stored in Trypticase soy broth (Difco) containing 50% glycerol at
80°C until use.
Quantitative antimicrobial susceptibility determination.
Antimicrobial MICs of E. coli isolates were determined via
the Sensititre automated antimicrobial susceptibility system (Trek Diagnostic Systems, Westlake, Ohio) and interpreted according to the
National Committee for Clinical Laboratory Standards (NCCLS) guidelines
for broth microdilution methods (20, 21). Sensititre susceptibility testing was performed according to the manufacturer's instructions. The following antimicrobials were tested: amikacin, amoxicillin-clavulanic acid, ampicillin, apramycin, ceftiofur, ceftriaxone, cephalothin, chloramphenicol, ciprofloxacin, florfenicol, gentamicin, kanamycin, nalidixic acid, streptomycin, sulfamethoxazole, tetracycline, and trimethoprim-sulfamethoxazole. E. coli
ATCC 25922 and 35218, Enterococcus faecalis ATCC 29212, Staphyloccoccus aureus ATCC 29213, and Pseudomonas
aeruginosa ATCC 27853 were used as controls in antimicrobial MIC determinations.
Bacterial DNA preparation, PCR, and DNA sequencing.
Bacterial DNA used for PCR was prepared by boiling a bacterial culture
in 500 µl of distilled water for 10 min, followed by centrifugation.
Isolates were initially characterized for STEC-associated virulence
genes, stx-1 and stx-2 coding for Shiga toxins,
eae for intimin that is associated with attaching and
effacing lesion, and hlyA for hemolysin (18).
The presence of class 1 integrons and the associated sulfonamide
resistance gene (sul-1) and integrase gene (int)
were detected using the PCR method described by Levesque et al.
(14) and Sandvang et al. (28). Class 1 integrons were amplified using the following PCR primers: 5'-CS
(5'-GGCATCCAAGCACAAGC-3') and 3'-CS
(5'-AAGCAGACTTGACTGAT-3'). The class 1 integrase gene and
sulfonamide resistance gene were also amplified as described above, but
the following primers were used: int-F
(5'-CCTCCCGCACGATGATC-3'), int-R
(5'-TCCACGCATCGTCAGGC-3'), sul1-F
(5'-CTTCGATGAGAGCCGGCGGC-3'), and sul1-R
(5'-GCAAGGCGGAAACCCGCGCC-3'). All primers were synthesized by Life Technologies (Gaithersburg, Md.). Amplification reactions were
carried out with 10 µl of boiled bacterial suspensions, 250 µM
deoxynucleoside triphosphate, 2.5 mM MgCl2, 50 pmol of
primers, and 1 U of Gold Taq polymerase (Perkin-Elmer,
Foster City, Calif.). Distilled water was added to bring the final
volume to 50 µl. The PCR cycle for class 1 integron and integrase
gene included an initial denaturation at 94°C for 10 min, followed by
30 cycles of denaturation for 1 min at 94°C, primer annealing for 1 min at 54°C, and extension for 2 min at 72°C, and a final extension at 72°C for 10 min. The PCR cycle for amplification of the
sul-1 gene was identical to that described above, except for
the annealing temperature, which was 59°C. The reaction products were
then analyzed by electrophoresis in 1.0% agarose gels stained with
ethidium bromide, visualized under UV light, and recorded by using a
gel documentation system (Bio-Rad, Hercules, Calif.). For each set of
PCR reactions, serovar Typhimurium DT104 CVM786 was included as a
positive control. The PCR-generated DNA fragments were then purified
using a PCR purification kit (Boehringer Mannheim, Indianapolis, Ind.)
and sequenced in an ABI automatic DNA sequencer (Model 377; Perkin-Elmer) at the University of Maryland Biotechnology Institute by
using the above-described forward and reverse primers. DNA sequences
were analyzed by searching the GenBank database of the National Center
for Biotechnology Information via the BLAST network service. The
E. coli O157:H7 integron sequence has been assigned the
GenBank accession number AF234167.
Southern blot hybridization.
Southern blot hybridizations
were performed to determine the locations of identified integrons.
Genomic and plasmid DNA were isolated from integron-positive STEC
isolates using the High Pure Plasmid Isolation Kit (Boehringer
Mannheim). Genomic and plasmid DNA were both digested with
BamHI. The class 1 integrase gene was used as a DNA probe
and was labeled with digoxigenin using the PCR DIG Probe Synthesis Kit
(Boehringer Mannheim). Digested DNA was run in 1% agarose gels and
transferred to nylon membranes. Hybridization procedures and conditions
were performed as specified with a nonradioactive labeling and
detection kit (Boehringer Mannheim).
Conjugation experiments.
E. coli O157:H7 strain
CVM990 and E. coli O111:NM strain CVM1884 that possessed
integrons were used as donor strains. E. coli O157:H7 strain
JM263 and H. alvei strains CVM1202, CVM1203, and CVM1208
were used as recipient strains (see Table 4). Streptomycin and
tetracycline resistance were used as selective markers for E. coli O157:H7 strains CVM990 and CVM1884, respectively, based on
their antibiotic resistance phenotypes (see Table 4). Nalidixic acid
and ampicillin resistance were used as selective markers for E. coli O157:H7 JM263 and H. alvei strains CVM1202,
CVM1203, and CVM1208, respectively. Conjugation was performed by mating a donor strain with a recipient strain on Trypticase soy agar (TSA;
Difco) plates (36). After incubation at 37°C overnight, the mating mixture was streaked onto a TSA plate containing a combination of selective antibiotics dependent upon the donor and
recipient strains used (100 µg of streptomycin and 100 µg of
nalidixic acid per ml, 100 µg of streptomycin and 100 µg of ampicillin per ml, 30 µg of tetracycline and 100 µg of nalidixic acid per ml, or 30 µg of tetracycline and 100 µg of ampicillin per
ml). Transconjugants were examined for antibiotic susceptibility profiles, and integron transfer was confirmed via PCR assays and/or DNA sequencing.
PFGE.
Pulsed-field gel electrophoresis (PFGE) was performed
to determine DNA fingerprinting profiles of donors, recipients, and transconjugates and to verify the gene transfer from donor to recipient
strains. The PFGE procedure of the Centers for Disease Control and
Prevention was used. Briefly, bacteria were grown on TSA plates
supplemented with 5% defibrinated sheep blood (Becton Dickinson
Microbiology Systems, Cockeysville, Md.) at 37°C for 18 h.
Bacterial colonies were suspended in cell suspension buffer (100 mM
Tris HCl, 100 mM EDTA; pH 8.0) and adjusted to an optical density of
0.50 to 0.54 using Dade MicroScan Turbidity Meter (Dade Behring, Inc.,
West Sacramento, Calif.). The cell suspension (200 µl) was mixed with
10 µl of proteinase K (10 mg/ml) and an equal volume of melted 1%
SeaKem Gold agarose (FMC BioProducts, Rockville, Maine) containing 1%
sodium dodecyl sulfate. The mixture was carefully dispensed into a
sample mold (Bio-Rad). After solidification, the plugs were transferred
to a tube containing 5 ml of lysis buffer (50 mM Tris HCl; 50 mM EDTA,
pH 8.0; 1% sarcosyl) and 0.1 mg of proteinase K per ml. Cells were
lysed overnight in a water bath at 54°C with agitation at 180 rpm.
After lysis, the plugs were washed twice with distilled water and four
times with TE buffer (10 mM Tris HCl, 1 mM EDTA; pH 8.0) for 15 min per
wash at 50°C with agitation at 180 rpm. Agarose-embedded DNA was
digested with 50 U of XbaI (Boehringer Mannheim) overnight
in a water bath at 37°C. The plugs were placed in a 1% SeaKem Gold
agarose gel. Restriction fragments were separated by electrophoresis in
0.5× TBE (Tris-borate-EDTA) buffer at 14°C for 18 h using a
Chef Mapper (Bio-Rad) with pulse times of 2.16 to 54.17 s. The gel was
stained with ethidium bromide, and DNA bands were visualized with a UV transilluminator.
 |
RESULTS |
Antimicrobial susceptibility profiles.
The antimicrobial
susceptibilities of 21 non-O157 and 29 O157:H7 STEC isolates were
determined using microbroth dilution (Table 2). All E. coli
O157:H7 isolates tested were resistant to at least one antibiotic,
which agreed with results from our previous study using disk diffusion
in vitro susceptibility testing (19). The majority of the
E. coli O157:H7 isolates were resistant to several
antimicrobials tested, particularly sulfamethoxazole (93%), tetracycline (93%), and streptomycin (76%). E. coli
O157:H7 isolates were also resistant to kanamycin (21%) and ampicillin
(14%). Several isolates were resistant to multiple antimicrobial
agents, and the most common pattern was resistance to
streptomycin, sulfamethoxazole, and tetracycline. Four E. coli O157:H7 isolates were multiple resistant to five
antibiotics: ampicillin, kanamycin, streptomycin, sulfamethoxazole, and
tetracycline. Two of these isolates (CVM73 and CVM1001) were
isolated from cattle in 1991 and 1992, respectively, one (CVM90)
was from a human sample, and the fourth (CVM79) was obtained from
ground beef in 1988.
The majority of the non-O157:H7 isolates displayed resistance to
multiple antimicrobials compared to the
E. coli O157:H7
isolates
(Table
2). Resistance to chloramphenicol (29%),
trimethoprim-sulfamethoxazole
(19%), cephalothin (19%),
florfenicol (10%), and amoxicillin-clavulanic
acid (5%) was only
observed among non-O157:H7 isolates (Table
2). CVM1877 (O111:H8)
and CVM1889 (O45:H2) were resistant to
seven antibiotics: ampicillin,
chloramphenicol, kanamycin, streptomycin,
sulfamethoxazole,
tetracycline, and either cephalothin or
trimethoprim-sulfamethoxazole.
CVM1879 (O111:H11) was multiply
resistant to nine antibiotics,
including ampicillin, cephalothin,
chloramphenicol, florfenicol,
kanamycin,
streptomycin, sulfamethoxazole, tetracycline, and
trimethoprim-sulfamethoxazole.
Four
non-O157:H7 isolates (CVM1877, CVN1878, CVM1879, and CVM1889)
were resistant to kanamycin and
chloramphenicol.
Presence of class one integrons and integron-associated genes.
Class 1 integrons were identified among nine STEC isolates representing
multiple serotypes: O157:H7, O111:H11, O111:H8, O111:NM, O103:H2,
O45:H2, and O26:H11 (Table 3). The
majority of integron amplified fragments were 1 kb in size, except for
one E. coli O111:H8 isolate which contained a 2-kb amplicon.
DNA sequence analysis revealed that the integrons identified within the
O111:H11, O111:H8, O111:NM, O45:H2, and O26:H11 isolates contained the
aadA gene encoding resistance to streptomycin-spectinomycin.
Integrons identified among the O157:H7 and O103:H2 isolates also
possessed a similar aadA gene; however, DNA sequencing
revealed only 86 and 88% homology, respectively. The 2-kb integron of
the E. coli O111:H8 isolate contained three genes, i.e.,
dfrXII encoding trimethoprim resistance, aadA2
encoding resistance to streptomycin and spectinomycin, and a gene of
unknown function, orfF, which were 86, 100, and 100%
homologous to previously reported gene cassettes identified in
integrons found in Citrobacter freundii and Klebsiella
pneumoniae, respectively. All integron-positive STEC strains were
positive for int-1 and sul-1. Figure
1 shows the PCR amplicons of
sul-1 (417 bp) and int-1 (280 bp) genes that are
present in class 1 integrons. Additionally, Southern blot
hybridizations indicated that class 1 integrons were located on
plasmids among the STEC isolates (data not shown).

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 1.
PCR amplicons of STEC integrons. Lanes 2 to 5 were
generated with the CS primers specific for class 1 integron. Lanes 6 to
9 were obtained using the sul primers specific for the
sul gene that confers sulfonamide resistance. Lanes 10 to 13 were obtained using the primers specific for integrase. Specifically,
lanes 2, 6, and 10 show positive controls (serovar Typhimurium DT104);
lanes 3, 7, and 11 show E. coli O111:H8 strain CVM1877;
lanes 4, 8, and 12 show E. coli O157:H7 strain CVM990;
and lanes 5, 9, and 13 show negative controls (E. coli
K-12).
|
|
Conjugal transfer of plasmids harboring class 1 integrons.
Conjugal transfer of plasmids carrying class 1 integrons occurred from
donor strains (O157:H7 CVM990 and O111:NM CVM1884) to recipient
strains (O157:H7 JM263 and H. alvei CVM1202, CVM1203, and CVM1208). Class 1 integrons were detected among transconjugants of
the recipient strains using integron-specific PCR assays (data not
shown). DNA fingerprinting by PFGE revealed that several
transconjugants, i.e., CVM990-JM263, CVM990-CVM1202, and
CVM990-CVM1208, acquired a 90-kb band when CVM990 was used as the
donor strain, whereas transconjugants CVM1884-JM263,
CVM1884-CVM1202, and CVM1884-CVM1208 gained a 127-kb
band when CVM1884 was used as the donor strain (Fig.
2)

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 2.
PFGE profiles with XbaI digestion of donor,
recipient, and transconjugant strains. Lanes 1 to 5 show, respectively,
results obtained with donor strains CVM990 (E. coli
O157:H7) and CVM1884, (E. coli O111:NM) and recipient
strains JM263 (E. coli O157:H7), H. alvei
CVM1202, and H. alvei CVM1203 before the conjugations. Lanes
6 to 8 show results with the transconjugants CVM990-JM263,
CVM990-CVM1202, and CVM990-CVM1203, respectively, that have gained a
90-kb band. Lanes 9 to 11 show results with the transconjugants
CVM1884-JM263, CVM1884-CVM1202, and CVM1884-CVM1203, respectively, that
have gained a 127-kb band.
|
|
Antimicrobial susceptibility testing of donor, recipient, and
transconjugant isolates revealed that all
Hafnia
transconjugants
acquired resistance to streptomycin, sulfamethoxazole,
and tetracycline
regardless of the donor strain (Table
4). Interestingly, in contrast
to
CVM1884-JM263, transconjugants CVM1884-CVM1202, CVM1884-CVM1203,
and
CVM1884-CVM1208 acquired streptomycin resistance even though
the donor
strain (CVM1884) was susceptible. DNA sequencing of
the integrons
amplified from both CVM1884 and transconjugant CVM1884-CVM1208
identified the identical
aadA1 gene that encodes resistance
to
streptomycin and spectinomycin. This most likely indicates that
although the
aadA1 gene was present in the donor strain
(CVM1884),
it was not being efficiently expressed from the integron
promoter.
None of the gene cassettes identified within the integrons
from
the STEC isolates conferred resistance to tetracycline, despite
the fact that all of the transconjugants acquired tetracycline
resistance. This may be due to the presence of the tetracycline
resistance gene on the same plasmid which contained the integrons
or on
a different plasmid that was cotransferred by conjugation
with the
integron-containing plasmid into the recipient cells.
 |
DISCUSSION |
The emergence and dissemination of antimicrobial resistance among
STEC strains may have potential negative clinical implications, although the diarrheal phase of illnesses associated with STEC strains
is usually self-limiting and the role of early antimicrobial therapy in
the prevention of HUS is still unclear (7).
Trimethoprim-sulfamethoxazole and
-lactam antibiotics are commonly
used for the treatment of gastroenteritis. In the case of STEC
infections, antibiotic treatment is not recommended. However, such
antibiotics are often administrated before the disease is diagnosed.
For children with acute bloody diarrhea, the most widely accepted
recommendation is to obtain a stool culture and initiate empirical
antibiotic treatment, because appropriate treatment shortens the
duration of the diarrhea, decreases the incidence of complications, and
reduces the risk of transmission by shortening the duration of
bacterial shedding (22).
Unfortunately, several studies, including the present study, have
revealed that many STEC strains have developed resistance to
trimethoprim-sulfamethoxazole,
-lactams, and other antibiotics. Additionally, the present study also demonstrated that STEC strains possess integrons which encode antibiotic resistance genes conferring resistance to trimethoprim and sulfamethoxazole. Antibiotic resistance and resistance integrons in STEC would not only complicate future antibiotic therapy but could also potentially stimulate the transfer of
resistance genes. Also, antibiotic-resistant STEC strains could possibly possess selective advantages over other bacteria colonizing the gastrointestinal tracts of animals that are treated with
antibiotics (therapeutically or subtherapeutically). Resistant STEC
strains could then become the predominant E. coli present
under antibiotic selective pressures. This could result in STEC
population increases and perhaps greater shedding, which could lead to
greater contamination of animal food products with STEC.
Integrons and gene cassettes have been found primarily in gram-negative
bacterial species belonging to the family
Enterobacteriaceae and to the Pseudomonas
genus (8, 27). Several studies have reported the presence
of class 1 integrons among clinical isolates of K. pneumoniae, K. oxytoca, P. aeruginosa, E. coli, and
C. freundii (12). Numerous studies have also
revealed that integron-borne gene cassettes are present among
S. enterica serotype Typhimurium isolates. A recent
study (26) reported that integrons were found in all 45 human and 21 animal isolates of Salmonella serovar
Typhimurium DT104 isolated between 1984 and 1997, including 58 isolates
from the United Kingdom and 8 isolates from other European countries, the United States, Trinidad, and South Africa. All strains had the
pentamer R-type of
ampicillin-chloramphenicol-streptomycin-sulfonamides-tetracycline (ACSSuT) and contained two integrons of approximately 1 and 1.2 kb.
These isolates also contained the same inserted gene cassettes, irrespective of source and country of origin, suggesting the spread of
an epidemic clone. Integrons have also been identified among veterinary
E. coli that were isolated from the normal intestinal flora
of swine (32) and diseased poultry (2). The
ant(3")-Ia (aadA) gene responsible for resistance to
streptomycin-spectinomycin was identified in all of the integrons
present in the swine E. coli. Other integron-associated
genes identified among the swine E. coli isolates included
dfr-1 encoding resistance to trimethoprim and the
-lactamase gene oxa-1. Integrons from 8 isolates were determined to be located on plasmids and were transferred to an E. coli DH5 laboratory strain. Additionally, Bass et al.
(2) reported that 63% of 100 clinical isolates of avian
E. coli exhibited class 1 integrons of approximately 1 kb.
These integrons were determined to contain the aadA1 gene
cassette conferring resistance to streptomycin-spectinomycin. This wide
distribution has presumably been achieved by the transposition of
integrons to broad-host-range plasmids. However, the role of integrons
in the acquisition and spread of antibiotic resistance has not yet been
fully investigated.
The present study reports the presence of class 1 integrons
conferring multiple resistance phenotypes among STEC strains
isolated from cattle, ground beef, and humans, which is, to our
knowledge, the first report on the presence of integrons in O157:H7
and non-O157 STEC strains. More significantly, the antibiotic
resistance phenotypes observed in STEC isolates were also transferable,
by conjugal plasmids, within species and between STEC and
Hafnia sp. (horizontal transfer). The integron-borne
aadA gene was silent in E. coli O111:NM, whereas
it was fully expressed when it was transferred to H. alvei,
suggesting that horizontal transfer may enhance the expression of a
resistance gene. As this and other studies have shown, many
integron-associated gene cassettes are identical, indicating that they
may originate from a common source and are readily disseminated among
bacteria. It is also evident that integrons conferring the same
resistance phenotype can be genetically different since more than one
gene cassette can encode resistance to one particular antibiotic. Some
STEC strains in our study contain an aadA cassette that
confers resistance to streptomycin and spectinomycin, but the gene
cassettes were only 86% identical, suggesting that they may have been
evolving independently for some time before their emergence in
antibiotic-resistant STEC.
E. coli O157:H7 is considered a newly emerged pathogen,
which may explain in part why integrons were only found in one strain among the 29 antibiotic-resistant strains tested. It is likely that
integrons will be identified among additional STEC isolates in the
future since this and other studies have demonstrated that integrons
are readily transferable through conjugation. However, integrons and
their associated gene cassettes did not always account for the total
phenotypic resistance exhibited by the STEC isolates. Several STEC
isolates displayed resistance to multiple antibiotics but did not
contain any gene cassettes conferring resistance. Clearly, other
mechanisms also contribute to the STEC antibiotic resistance phenotypes.
In summary, STEC strains have developed resistance to multiple classes
of antimicrobials. Integrons not only are associated with multiple
antibiotic resistance but also may play a significant role in the
dissemination of resistance genes. Although the findings of this study
strongly support the hypothesis that integrons provide a very efficient
strategy for the acquisition and dissemination of new antibiotic
resistance genes, a prospective long-term investigation of the natural
evolution of gene transfer among bacterial pathogens inhabiting food
animals is required.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Office of
Research, U.S. FDA/CVM, 8401 Muirkirk Rd., Laurel, MD 20708. Phone:
(301) 827-8139. Fax: (301) 827-8127. E-mail:
szhao{at}cvm.fda.gov.
 |
REFERENCES |
| 1.
|
Aarestrup, F. M., and H. C. Wegener.
1999.
The effects of antibiotic usage in food animals on the development of antimicrobial resistance of importance for humans in Campylobacter and Escherichia coli.
Microb. Infect.
1:639-644[CrossRef][Medline].
|
| 2.
|
Bass, L.,
C. A. Liebert,
M. D. Lee,
A. O. Summers,
D. G. White,
S. G. Thayer, and J. J. Maurer.
1999.
Incidence and characterization of integrons, genetic elements mediating multiple-drug resistance in avian Escherichia coli.
Antimicrob. Agents Chemother.
43:2925-2929[Abstract/Free Full Text].
|
| 3.
|
Bopp, C.,
K. Greene,
F. Downes,
E. Sowers,
J. Wells, and I. Wachsmuth.
1987.
Unusual verotoxin-producing Escherichia coli associated with hemorrhagic colitis.
J. Clin. Mcirobiol
25:1486-1489.
|
| 4.
|
Farina, C.,
A. Goglio,
G. Conedera,
F. Minelli, and A. Caprioli.
1996.
Antimicrobial susceptibility of Escherichia coli O157 and other enterohaemorrhagic Escherichia coli isolated in Italy.
Eur. J. Clin. Microbiol. Infect. Dis.
15:351-353[CrossRef][Medline].
|
| 5.
|
Fukushima, H.,
T. Hashizume,
Y. Morita,
J. Tanaka,
K. Azuma,
Y. Mizumoto,
M. Kaneno,
M. Matsuura,
K. Konma, and T. Kitani.
1999.
Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996.
Pediatr. Int.
41:213-217[CrossRef][Medline].
|
| 6.
|
Gonzalez, E. A., and J. Blanco.
1989.
Serotypes and antibiotic resistance of verotoxigenic (VTEC) and necrotizing (NTEC) Escherichia coli strains isolated from calves with diarrhoea.
FEMS Microbiol. Lett.
51:31-36[Medline].
|
| 7.
|
Griffin, P. M.
1995.
Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli, p. 739-761.
In
M. J. Blaser, P. D. Smith, J. I. Ravdin, H. B. Greenberg, and R. L. Guerrant (ed.), Infections of gastrointestinal tract. Raven Press, New York, N.Y.
|
| 8.
|
Hall, R. M.
1997.
Mobile gene cassettes and integrons: moving antibiotic resistance genes in gram-negative bacteria.
Ciba Found. Symp.
207:192-202[Medline].
|
| 9.
|
Hall, R. M., and H. W. Stokes.
1993.
Integrons: novel DNA elements which capture genes by site-specific recombination.
Genetica
90:115-132[CrossRef][Medline].
|
| 10.
|
Igarashi, T.,
J. Inatomi,
A. Wake,
M. Takamizawa,
H. Katayama, and T. Iwata.
1999.
Failure of pre-diarrheal antibiotics to prevent hemolytic uremic syndrome in serologically proven Escherichia coli O157:H7 gastrointestinal infection.
J. Pediatr.
135:768-769[CrossRef][Medline].
|
| 11.
|
Ikeda, K.,
O. Ida,
K. Kimoto,
T. Takatorige,
N. Nakanishi, and K. Tatara.
1999.
Effect of early fosfomycin treatment on prevention of hemolytic uremic syndrome accompanying Escherichia coli O157:H7 infection.
Clin. Nephrol.
52:357-362[Medline].
|
| 12.
|
Jones, M. E.,
E. Peters,
A. M. Weersink,
A. Fluit, and J. Verhoef.
1997.
Widespread occurrence of integrons causing multiple antibiotic resistance in bacteria.
Lancet
349:1742-1743[Medline].
|
| 13.
|
Kim, H. H.,
M. Samadpour,
L. Grimm,
C. R. Clausen,
T. E. Besser,
M. Baylor,
J. M. Kobayashi,
M. A. Neill,
F. D. Schoenknecht, and P. I. Tarr.
1994.
Characteristics of antibiotic-resistant Escherichia coli O157:H7 in Washington State, 1984-1991.
J. Infect. Dis.
170:1606-1609[Medline].
|
| 14.
|
Levesque, C.,
L. Piche,
C. Larose, and P. H. Roy.
1995.
PCR mapping of integrons reveals several novel combinations of resistance genes.
Antimicrob. Agents Chemother.
39:185-191[Abstract].
|
| 15.
|
Mazel, D.,
B. Dychinco,
V. A. Webb, and J. Davies.
1998.
A distinctive class of integron in the Vibrio cholerae genome.
Science
280:605-608[Abstract/Free Full Text].
|
| 16.
|
Mead, P. S.,
L. Slutsker,
V. Dietz,
L. F. McCaig,
J. S. Bresee,
C. Shapiro,
P. M. Griffin, and R. V. Tauxe.
1999.
Food-related illness and death in the United States.
Emerg. Infect. Dis.
5:607-625[Medline].
|
| 17.
|
Meng, J., and M. P. Doyle.
1998.
Microbiology of Shiga toxin-producing Escherichia coli in foods, p. 92-111.
In
J. Kaper, and A. O'Brien (ed.), Escherichia coli O157:H7 and other Shiga toxin-producing E. coli strains. ASM Press, Washington, D.C.
|
| 18.
|
Meng, J.,
S. Zhao, and M. P. Doyle.
1998.
Virulence genes of Shiga toxin-producing Escherichia coli isolated from food, animals and humans.
Int. J. Food Microbiol.
45:229-235[CrossRef][Medline].
|
| 19.
|
Meng, J.,
S. Zhao,
M. P. Doyle, and S. W. Joseph.
1998.
Antibiotic resistance of Escherichia coli O157:H7 and O157:NM isolated from animals, food, and humans.
J. Food Prot.
61:1511-1514[Medline].
|
| 20.
|
National Committee for Clinical Laboratory Standards.
2000.
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 21.
|
National Committee for Clinical Laboratory Standards.
1999.
Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. Approved standard M31-A.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 22.
|
O'Ryan, M., and V. Prado.
2000.
Risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.
N. Engl. J. Med.
343:1271[Free Full Text].
|
| 23.
|
Proulx, F.,
J. P. Turgeon,
G. Delage,
L. Lafleur, and L. Chicoine.
1992.
Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 enteritis.
J. Pediatr.
121:299-303[CrossRef][Medline].
|
| 24.
|
Ratnam, S.,
S. March,
R. Ahmed,
G. Bezanson, and S. Kasatiya.
1988.
Characterization of Escherichia coli serotype O157:H7.
J. Clin. Microbiol.
26:2006-2012[Abstract/Free Full Text].
|
| 25.
|
Recchia, G. D., and R. M. Hall.
1997.
Origins of the mobile gene cassettes found in integrons.
Trends Microbiol.
5:389-394[CrossRef][Medline].
|
| 26.
|
Ridley, A., and E. J. Threlfall.
1998.
Molecular epidemiology of antibiotic resistance genes in multiresistant epidemic Salmonella Typhimurium DT104.
Microb. Drug Resist.
4:113-118[Medline].
|
| 27.
|
Sallen, B.,
A. Rajoharison,
S. Desvarenne, and C. Mabilat.
1995.
Molecular epidemiology of integron-associated antibiotic resistance genes in clinical isolates of enterobacteriaceae.
Microb. Drug Resist.
1:195-202[Medline].
|
| 28.
|
Sandvang, D.,
F. M. Aarestrup, and L. B. Jensen.
1998.
Characterisation of integrons and antibiotic resistance genes in Danish multiresistant Salmonella enterica Typhimurium DT104.
FEMS Microbiol. Lett.
160:37-41[CrossRef][Medline].
|
| 29.
|
Schmidt, H.,
J. von Maldeghem,
M. Frosch, and H. Karch.
1998.
Antibiotic susceptibilities of verocytotoxin-producing Escherichia coli O157 and non-O157 strains isolated from patients and healthy subjects in Germany during 1996.
J. Antimicrob. Chemother.
42:548-550[Free Full Text].
|
| 30.
|
Shiomi, M.,
M. Togawa,
K. Fujita, and R. Murata.
1999.
Effect of early oral fluoroquinolones in hemorrhagic colitis due to Escherichia coli O157:H7.
Pediatr. Int.
41:228-232[CrossRef][Medline].
|
| 31.
|
Slutsker, L.,
A. Ries,
K. Greene,
J. Wells,
L. Hutwagner, and P. Griffin.
1997.
Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features.
Ann. Intern. Med.
126:505-513[Abstract/Free Full Text].
|
| 32.
|
Sunde, M., and H. Sorum.
1999.
Characterization of integrons in Escherichia coli of the normal intestinal flora of swine.
Microb. Drug Resist.
5:279-287[Medline].
|
| 33.
|
Tollefson, L.,
S. F. Altekruse, and M. E. Potter.
1997.
Therapeutic antibiotics in animal feeds and antibiotic resistance.
Rev. Sci. Tech.
16:709-715[Medline].
|
| 34.
|
Witte, W.
1998.
Medical consequences of antibiotic use in agriculture.
Science
279:996-997[Free Full Text].
|
| 35.
|
Yoh, M., and T. Honda.
1997.
The stimulating effect of fosfomycin, an antibiotic in common use in Japan, on the production/release of verotoxin-1 from enterohaemorrhagic Escherichia coli O157:H7 in vitro.
Epidemiol. Infect.
119:101-103[CrossRef][Medline].
|
| 36.
|
Zhao, S.,
J. Meng,
M. P. Doyle,
R. Meinersman,
G. Wang, and P. Zhao.
1996.
A low molecular weight outer-membrane protein of Escherichia coli O157:H7 associated with adherence to INT407 cells and chicken caeca.
J. Med. Microbiol.
45:90-96[Abstract/Free Full Text].
|
Applied and Environmental Microbiology, April 2001, p. 1558-1564, Vol. 67, No. 4
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.4.1558-1564.2001
This article has been cited by other articles:
-
Rosengren, L. B., Waldner, C. L., Reid-Smith, R. J.
(2009). Associations between Antimicrobial Resistance Phenotypes, Antimicrobial Resistance Genes, and Virulence Genes of Fecal Escherichia coli Isolates from Healthy Grow-Finish Pigs. Appl. Environ. Microbiol.
75: 1373-1380
[Abstract]
[Full Text]
-
Nagachinta, S., Chen, J.
(2008). Transfer of Class 1 Integron-Mediated Antibiotic Resistance Genes from Shiga Toxin-Producing Escherichia coli to a Susceptible E. coli K-12 Strain in Storm Water and Bovine Feces. Appl. Environ. Microbiol.
74: 5063-5067
[Abstract]
[Full Text]
-
Ziebell, K., Steele, M., Zhang, Y., Benson, A., Taboada, E. N., Laing, C., McEwen, S., Ciebin, B., Johnson, R., Gannon, V.
(2008). Genotypic Characterization and Prevalence of Virulence Factors among Canadian Escherichia coli O157:H7 Strains. Appl. Environ. Microbiol.
74: 4314-4323
[Abstract]
[Full Text]
-
Lynne, A. M., Rhodes-Clark, B. S., Bliven, K., Zhao, S., Foley, S. L.
(2008). Antimicrobial Resistance Genes Associated with Salmonella enterica Serovar Newport Isolates from Food Animals. Antimicrob. Agents Chemother.
52: 353-356
[Abstract]
[Full Text]
-
Vali, L., Hamouda, A., Hoyle, D. V., Pearce, M. C., Whitaker, L. H. R., Jenkins, C., Knight, H. I., Smith, A. W., Amyes, S. G. B.
(2007). Antibiotic resistance and molecular epidemiology of Escherichia coli O26, O103 and O145 shed by two cohorts of Scottish beef cattle. J Antimicrob Chemother
59: 403-410
[Abstract]
[Full Text]
-
Blahna, M. T., Zalewski, C. A., Reuer, J., Kahlmeter, G., Foxman, B., Marrs, C. F.
(2006). The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada. J Antimicrob Chemother
57: 666-672
[Abstract]
[Full Text]
-
Sunde, M.
(2005). Prevalence and characterization of class 1 and class 2 integrons in Escherichia coli isolated from meat and meat products of Norwegian origin. J Antimicrob Chemother
56: 1019-1024
[Abstract]
[Full Text]
-
Corkill, J. E., Anson, J. J., Hart, C. A.
(2005). High prevalence of the plasmid-mediated quinolone resistance determinant qnrA in multidrug-resistant Enterobacteriaceae from blood cultures in Liverpool, UK. J Antimicrob Chemother
56: 1115-1117
[Abstract]
[Full Text]
-
Ahmed, A. M, Kawamoto, H., Inouye, K., Hashiwata, Y., Sakaki, M., Seno, M., Shimamoto, T.
(2005). Genomic analysis of a multidrug-resistant strain of enterohaemorrhagic Escherichia coli O157 : H7 causing a family outbreak in Japan. J Med Microbiol
54: 867-872
[Abstract]
[Full Text]
-
DebRoy, C., Fratamico, P. M., Roberts, E., Davis, M. A., Liu, Y.
(2005). Development of PCR Assays Targeting Genes in O-Antigen Gene Clusters for Detection and Identification of Escherichia coli O45 and O55 Serogroups. Appl. Environ. Microbiol.
71: 4919-4924
[Abstract]
[Full Text]
-
Sunde, M., Norstrom, M.
(2005). The genetic background for streptomycin resistance in Escherichia coli influences the distribution of MICs. J Antimicrob Chemother
56: 87-90
[Abstract]
[Full Text]
-
Singh, R., Schroeder, C. M., Meng, J., White, D. G., McDermott, P. F., Wagner, D. D., Yang, H., Simjee, S., DebRoy, C., Walker, R. D., Zhao, S.
(2005). Identification of antimicrobial resistance and class 1 integrons in Shiga toxin-producing Escherichia coli recovered from humans and food animals. J Antimicrob Chemother
56: 216-219
[Abstract]
[Full Text]
-
Levings, R. S., Partridge, S. R., Lightfoot, D., Hall, R. M., Djordjevic, S. P.
(2005). New Integron-Associated Gene Cassette Encoding a 3-N-Aminoglycoside Acetyltransferase. Antimicrob. Agents Chemother.
49: 1238-1241
[Abstract]
[Full Text]
-
Ahmed, A. M, Miyoshi, S.-i., Shinoda, S., Shimamoto, T.
(2005). Molecular characterization of a multidrug-resistant strain of enteroinvasive Escherichia coli O164 isolated in Japan. J Med Microbiol
54: 273-278
[Abstract]
[Full Text]
-
Kahali, S., Sarkar, B., Rajendran, K., Khanam, J., Yamasaki, S., Nandy, R. K., Bhattacharya, S. K., Ramamurthy, T.
(2004). Virulence Characteristics and Molecular Epidemiology of Enteroaggregative Escherichia coli Isolates from Hospitalized Diarrheal Patients in Kolkata, India. J. Clin. Microbiol.
42: 4111-4120
[Abstract]
[Full Text]
-
Yang, H., Chen, S., White, D. G., Zhao, S., McDermott, P., Walker, R., Meng, J.
(2004). Characterization of Multiple-Antimicrobial-Resistant Escherichia coli Isolates from Diseased Chickens and Swine in China. J. Clin. Microbiol.
42: 3483-3489
[Abstract]
[Full Text]
-
Ahmed, A. M., Nakagawa, T., Arakawa, E., Ramamurthy, T., Shinoda, S., Shimamoto, T.
(2004). New aminoglycoside acetyltransferase gene, aac(3)-Id, in a class 1 integron from a multiresistant strain of Vibrio fluvialis isolated from an infant aged 6 months. J Antimicrob Chemother
53: 947-951
[Abstract]
[Full Text]
-
Ebner, P., Garner, K., Mathew, A.
(2004). Class 1 integrons in various Salmonella enterica serovars isolated from animals and identification of genomic island SGI1 in Salmonella enterica var. Meleagridis. J Antimicrob Chemother
53: 1004-1009
[Abstract]
[Full Text]
-
Chen, S., Zhao, S., White, D. G., Schroeder, C. M., Lu, R., Yang, H., McDermott, P. F., Ayers, S., Meng, J.
(2004). Characterization of Multiple-Antimicrobial-Resistant Salmonella Serovars Isolated from Retail Meats. Appl. Environ. Microbiol.
70: 1-7
[Abstract]
[Full Text]
-
Zhao, S., Qaiyumi, S., Friedman, S., Singh, R., Foley, S. L., White, D. G., McDermott, P. F., Donkar, T., Bolin, C., Munro, S., Baron, E. J., Walker, R. D.
(2003). Characterization of Salmonella enterica Serotype Newport Isolated from Humans and Food Animals. J. Clin. Microbiol.
41: 5366-5371
[Abstract]
[Full Text]
-
White, D. G., Datta, A., McDermott, P., Friedman, S., Qaiyumi, S., Ayers, S., English, L., McDermott, S., Wagner, D. D., Zhao, S.
(2003). Antimicrobial susceptibility and genetic relatedness of Salmonella serovars isolated from animal-derived dog treats in the USA. J Antimicrob Chemother
52: 860-863
[Abstract]
[Full Text]
-
Maynard, C., Fairbrother, J. M., Bekal, S., Sanschagrin, F., Levesque, R. C., Brousseau, R., Masson, L., Lariviere, S., Harel, J.
(2003). Antimicrobial Resistance Genes in Enterotoxigenic Escherichia coli O149:K91 Isolates Obtained over a 23-Year Period from Pigs. Antimicrob. Agents Chemother.
47: 3214-3221
[Abstract]
[Full Text]
-
Byrne, C. M., Erol, I., Call, J. E., Kaspar, C. W., Buege, D. R., Hiemke, C. J., Fedorka-Cray, P. J., Benson, A. K., Wallace, F. M., Luchansky, J. B.
(2003). Characterization of Escherichia coli O157:H7 from Downer and Healthy Dairy Cattle in the Upper Midwest Region of the United States. Appl. Environ. Microbiol.
69: 4683-4688
[Abstract]
[Full Text]
-
Mc Dermott, P. F., Walker, R. D., White, D. G.
(2003). Antimicrobials: Modes of Action and Mechanisms of Resistance. International Journal of Toxicology
22: 135-143
[Abstract]
-
Lindstedt, B.-A., Heir, E., Nygard, I., Kapperud, G.
(2003). Characterization of class I integrons in clinical strains of Salmonella enterica subsp. enterica serovars Typhimurium and Enteritidis from Norwegian hospitals. J Med Microbiol
52: 141-149
[Abstract]
[Full Text]
-
Bettelheim, K. A., Hornitzky, M. A., Djordjevic, S. P., Kuzevski, A.
(2003). Antibiotic resistance among verocytotoxigenic Escherichia coli (VTEC) and non-VTEC isolated from domestic animals and humans. J Med Microbiol
52: 155-162
[Abstract]
[Full Text]
-
Maidhof, H., Guerra, B., Abbas, S., Elsheikha, H. M., Whittam, T. S., Beutin, L.
(2002). A Multiresistant Clone of Shiga Toxin-Producing Escherichia coli O118:[H16] Is Spread in Cattle and Humans over Different European Countries. Appl. Environ. Microbiol.
68: 5834-5842
[Abstract]
[Full Text]
-
Khan, A., Das, S. C., Ramamurthy, T., Sikdar, A., Khanam, J., Yamasaki, S., Takeda, Y., Nair, G. B.
(2002). Antibiotic Resistance, Virulence Gene, and Molecular Profiles of Shiga Toxin-Producing Escherichia coli Isolates from Diverse Sources in Calcutta, India. J. Clin. Microbiol.
40: 2009-2015
[Abstract]
[Full Text]
-
Schroeder, C. M., Zhao, C., DebRoy, C., Torcolini, J., Zhao, S., White, D. G., Wagner, D. D., McDermott, P. F., Walker, R. D., Meng, J.
(2002). Antimicrobial Resistance of Escherichia coli O157 Isolated from Humans, Cattle, Swine, and Food. Appl. Environ. Microbiol.
68: 576-581
[Abstract]
[Full Text]
-
Zhao, S., White, D. G., McDermott, P. F., Friedman, S., English, L., Ayers, S., Meng, J., Maurer, J. J, Holland, R., Walker, R. D.
(2001). Identification and Expression of Cephamycinase blaCMY Genes in Escherichia coli and Salmonella Isolates from Food Animals and Ground Meat. Antimicrob. Agents Chemother.
45: 3647-3650
[Abstract]
[Full Text]